Top Markets
#1 Ontology Gas Ontology Gas +25.55%
#2 Verus Coin Verus Coin +20.23%
#3 Derive Derive +17.29%
#4 Geodnet Geodnet +17.25%
#5 Status Status +15.25%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.03%
#7 Pons Pons +12.79%
#8 Ergo Ergo +11.20%
#9 ETHGas ETHGas +10.52%
#10 Curve DAO Curve DAO +9.95%
Coin of the day
Ontology Gas Ontology Gas
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Greenyn Biotechnology Co., Ltd Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltd

6846
Clasificación en acciones #25469
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary... Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Precio por acción
$1.82
Capitalización bursátil
$49.14M
Cambio (1 día)
-0.35%
Cambio (1 año)
-25.79%
País
TW
Comercio Greenyn Biotechnology Co., Ltd (6846)

Categoría

Healthcare
Margen Operativo de Greenyn Biotechnology Co., Ltd (6846)
Margen Operativo al 2026 TTM: 0.00%
Según los informes financieros más recientes y el precio de las acciones de Greenyn Biotechnology Co., Ltd, el margen operativo actual (TTM) es 0.00%. Al final de 2026, el margen operativo era 0.00%.
Historial de Margen Operativo de Greenyn Biotechnology Co., Ltd desde 2026 hasta 2026
Margen Operativo al final de cada año
Año Margen Operativo Cambiar
Not enough data for the provided dates.
Margen Operativo de empresas similares o competidoras
Empresa Margen Operativo Diferencia de Margen Operativo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.